中华消化外科杂志
中華消化外科雜誌
중화소화외과잡지
CHINESE JOURNAL OF DIGESTIVE SURGERY
2008年
6期
428-430
,共3页
冯晓彬%艾军华%郑树国%王曙光%别平
馮曉彬%艾軍華%鄭樹國%王曙光%彆平
풍효빈%애군화%정수국%왕서광%별평
肝肿瘤%肝移植%槐耳颗粒%化学疗法
肝腫瘤%肝移植%槐耳顆粒%化學療法
간종류%간이식%괴이과립%화학요법
Liver neoplams%Liver transplantation%Huaier granule%Chemotherapy
目的 探讨槐耳颗粒对肝癌肝移植术后患者的辅助治疗效果.方法 将2004年7月至2006年6月符合UCSF标准的肝癌肝移植患者60例分为槐耳颗粒组(20例)、化疗组(15例)、槐耳颗粒+化疗组(15例)和对照组(10例).观察各组的白细胞、肝功能、细胞免疫功能指标、免疫排斥反应情况,并统计术后1年肿瘤复发率.结果 化疗组白细胞在治疗后1、3、6个月较治疗前明显减低(F=62.053,58.472,49.807,P<0.05);其余3组治疗前后变化不大;4组比较差异有统计学意义(F=102.361,113.412,87.572,P<0.05).槐耳颗粒组和槐耳颗粒+化疗组NK细胞活性、CD4+/CD8+比值、IL-2水平在治疗后1、3、6个月显著高于治疗前,并显著高于化疗组和对照组(P<0.05).各组在观察期间均未出现急性免疫排斥反应;术后1年各组均有2例患者出现复发、转移,对照组发生率高于其余3组(P<0.05).结论 槐耳颗粒能改善肝癌肝移植患者术后化疗所致的白细胞减少,增强患者的细胞免疫功能,能有效抑制肿瘤在术后1年内的复发、转移.
目的 探討槐耳顆粒對肝癌肝移植術後患者的輔助治療效果.方法 將2004年7月至2006年6月符閤UCSF標準的肝癌肝移植患者60例分為槐耳顆粒組(20例)、化療組(15例)、槐耳顆粒+化療組(15例)和對照組(10例).觀察各組的白細胞、肝功能、細胞免疫功能指標、免疫排斥反應情況,併統計術後1年腫瘤複髮率.結果 化療組白細胞在治療後1、3、6箇月較治療前明顯減低(F=62.053,58.472,49.807,P<0.05);其餘3組治療前後變化不大;4組比較差異有統計學意義(F=102.361,113.412,87.572,P<0.05).槐耳顆粒組和槐耳顆粒+化療組NK細胞活性、CD4+/CD8+比值、IL-2水平在治療後1、3、6箇月顯著高于治療前,併顯著高于化療組和對照組(P<0.05).各組在觀察期間均未齣現急性免疫排斥反應;術後1年各組均有2例患者齣現複髮、轉移,對照組髮生率高于其餘3組(P<0.05).結論 槐耳顆粒能改善肝癌肝移植患者術後化療所緻的白細胞減少,增彊患者的細胞免疫功能,能有效抑製腫瘤在術後1年內的複髮、轉移.
목적 탐토괴이과립대간암간이식술후환자적보조치료효과.방법 장2004년7월지2006년6월부합UCSF표준적간암간이식환자60례분위괴이과립조(20례)、화료조(15례)、괴이과립+화료조(15례)화대조조(10례).관찰각조적백세포、간공능、세포면역공능지표、면역배척반응정황,병통계술후1년종류복발솔.결과 화료조백세포재치료후1、3、6개월교치료전명현감저(F=62.053,58.472,49.807,P<0.05);기여3조치료전후변화불대;4조비교차이유통계학의의(F=102.361,113.412,87.572,P<0.05).괴이과립조화괴이과립+화료조NK세포활성、CD4+/CD8+비치、IL-2수평재치료후1、3、6개월현저고우치료전,병현저고우화료조화대조조(P<0.05).각조재관찰기간균미출현급성면역배척반응;술후1년각조균유2례환자출현복발、전이,대조조발생솔고우기여3조(P<0.05).결론 괴이과립능개선간암간이식환자술후화료소치적백세포감소,증강환자적세포면역공능,능유효억제종류재술후1년내적복발、전이.
Objective To investigate the auxiliary effects of huaier granule on hepatoeellular carcinoma (HCC)patients after liver transplantation.Methods Sixty HCC patients who had undergone liver transplantation from Julv 2004 to June 2006 and met the standard of UCSF were involved in this study.All patients were divided into huaier granule group(n=20),chemotherapy group(n=15),huaier granule+chemotherapy group (n=15)and control group(n=10).The white blood cell count,liver function,cell immunity and immunologieal reiection were detected.The 1-year tumor recurrence rate wag calculated.Results The white blood cell counts in chemotherapy group 1,3,and 6 months after treatment were significantly lower than that before treatment (F=62.053,58.472,49.807,P<0.05).The changes of white blood cell counts of the other 3 groups before and aftertreatment were small.The difference on the white blood cell counts of the 4 groups had no statistical 8ignincanee(F=102.361,113.412,87.572,P<0.05).The NK activity,CD4+/CD8+ ratio,IL-2 level in huaier granule group and huaier granule+chemotherapy group 1,3,6 months after treatment were significantly higher than those before treatment,and were significantly higher than those in chemotherapy group and control group(P<0.05).No immunological rejection occurred in all the groups.Two patients in each group had recurrence and metastasis of HCC within 1 year after the treatment.and the incidence in control group was higher than the other 3 groups(P<0.05). Conclusions Humer granule can increase the white blood cell count which is decreased after chemotherapy,impmve cellular immunity,and effectively suppress the recurrence and metastasis of HCC at the first year after operation.